Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of MOEX Group (Moscow Exchange) recommended that dividends be paid for 2024

4/4/25 MOEX

Turnover for the first month of weekend trading totaled ₽47 billion

4/4/25 MOEX

Astra Group reported for 2024 under RAS

4/4/25 ASTR

Softline launched production of the first Russian payment terminal

4/4/25 SOFL

Alrosa completes cutting of the largest diamond in Russia

4/4/25 ALRS

Supl.biz valuation may grow 2-fold by the end of the year

4/4/25 OTCI

Kamaz expects to occupy 50% of the truck market by 2025

4/4/25 KMAZ

Lambumiz reported for 2024 by RAS

4/4/25 LMBZ

Buryatzoloto reported for 2024 under RAS

4/3/25 BRZL

Abrau-Durso reported for 2024 by RAS

4/3/25 ABRD